Effect of tissue factor pathway inhibitor on thrombin generation assay

Int J Lab Hematol. 2022 Jun;44(3):e115-e119. doi: 10.1111/ijlh.13758. Epub 2021 Nov 15.

Marie Didembourg¹, Jonathan Douxfils^{1

2}, Audrey Carlo³, François Mullier⁴, Michael Hardy^{4

5}, Laure Morimont^{1

2}

¹ Department of Pharmacy, Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), Namur Thrombosis and Hemostasis Center (NTHC), University of Namur, Namur, Belgium.
² Qualiblood s.a., Namur, Belgium.
³ Diagnostica Stago, Asnière-sur-Seine, France.
⁴ Hematology Laboratory, Namur Research Institute for Life Sciences (NARILIS), Namur Thrombosis and Hemostasis Center (NTHC), Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.
⁵ Department of Anesthesiology, Namur Research Institute for Life Sciences (NARILIS), Namur Thrombosis and Hemostasis Center (NTHC), Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.

No abstract available

Keywords: Global coagulation test; Heparin; TFPI; thrombin generation test; thromboembolic event.

Publication types